Latest report
Q3 2026
filed Nov 6, 2026
Reported value
$88.3B
−$10.7B (10.8%) vs Q2 2026
Positions
29
28 in Q2 2026
Top 10 share
99.5%
of reported value
CheckedEach line's price per share is checked against other managers' reports of the same stock. Unit mix-ups are corrected. Reports no fix can rescue are left out.
Clean
prices match other managers' reports

Holdings, Q3 2026

Largest first. Common shares only.

Latest 13F holdings
#The fund's own figures at the end of the quarter. A report can be up to 45 days old when it is filed. Options and bonds are not counted here.Filing
1SPCX
Space Exploration Technologies Corp.
555.04M$83.7B94.8%+0.7%13F ↗
2CME
CME Group Inc.
3.48M$912.7M1.0%Unchanged13F ↗
3PL
Planet Labs PBC
35.25M$577.7M0.7%Unchanged13F ↗
4ARM
Arm Holdings plc
1.96M$568.0M0.6%Unchanged13F ↗
5RVMD
Revolution Medicines, Inc.
2.67M$548.8M0.6%-9.3%13F ↗
6QCOM
QUALCOMM Incorporated
2.98M$547.9M0.6%New13F ↗
7ASTS
AST SpaceMobile, Inc.
8.94M$526.4M0.6%Unchanged13F ↗
8FRSH
Freshworks Inc.
14.34M$183.4M0.2%-11.5%13F ↗
9PBLS
Parabilis Medicines, Inc.
4.92M$158.9M0.2%Unchanged13F ↗
10TEM
Tempus AI, Inc.
1.55M$127.0M0.1%Unchanged13F ↗
11PATH
UiPath, Inc.
7.03M$90.3M0.1%Unchanged13F ↗
12LIME
Neutron Holdings, Inc.
1.90M$53.5M0.1%New13F ↗
13PRME
Prime Medicine, Inc.
16.56M$50.7M0.1%Unchanged13F ↗
14PAYP
PayPay Corporation · ADR
3.13M$49.1M0.1%Unchanged13F ↗
15MAZE
Maze Therapeutics, Inc.
1.39M$37.7M<0.1%Unchanged13F ↗
16FRNM
Freenome, Inc.
2.02M$31.8M<0.1%New13F ↗
17RLAY
Relay Therapeutics, Inc.
1.41M$25.5M<0.1%Unchanged13F ↗
18FRVO
Fervo Energy Company
1.76M$23.9M<0.1%Unchanged13F ↗
19LIFE
Ethos Technologies Inc.
571,907$19.2M<0.1%-84.2%13F ↗
20OBX
Obsidian Therapeutics, Inc.
1.22M$16.8M<0.1%New13F ↗
21OSCR
Oscar Health, Inc.
481,988$14.9M<0.1%Unchanged13F ↗
22BBOT
BridgeBio Oncology Therapeutics, Inc.
2.82M$11.6M<0.1%Unchanged13F ↗
23SANA
Sana Biotechnology, Inc.
2.81M$8.2M<0.1%Unchanged13F ↗
24BEAM
Beam Therapeutics Inc.
321,604$7.9M<0.1%Unchanged13F ↗
25VERA
Vera Therapeutics, Inc.
241,264$7.8M<0.1%Unchanged13F ↗
26FIG
Figma, Inc.
215,582$4.5M<0.1%Unchanged13F ↗
27GLUE
Monte Rosa Therapeutics, Inc.
372,474$4.4M<0.1%Unchanged13F ↗
28LYEL
Lyell Immunopharma, Inc.
293,256$2.9M<0.1%Unchanged13F ↗
29HYPR
Hyperfine, Inc.
898,720$728.0K<0.1%Unchanged13F ↗

Ten largest positions

By value, Q3 2026.

$0$50.0B$100.0BSPCX · Value: $83,733,871,462SPCXCME · Value: $912,743,560CMEPL · Value: $577,729,380PLARM · Value: $567,960,693ARMRVMD · Value: $548,846,561RVMDQCOM · Value: $547,883,767QCOMASTS · Value: $526,413,586ASTSFRSH · Value: $183,365,664FRSHPBLS · Value: $158,850,590PBLSTEM · Value: $127,035,254TEM

Information, not investment advice. Values are the fund's own figures at quarter end; a report can be up to 45 days old when filed. Disclaimer